Does CILTACABTAGENE AUTOLEUCEL Cause Neoplasm malignant? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Neoplasm malignant have been filed in association with CILTACABTAGENE AUTOLEUCEL (CARVYKTI). This represents 0.3% of all adverse event reports for CILTACABTAGENE AUTOLEUCEL.
13
Reports of Neoplasm malignant with CILTACABTAGENE AUTOLEUCEL
0.3%
of all CILTACABTAGENE AUTOLEUCEL reports
6
Deaths
2
Hospitalizations
How Dangerous Is Neoplasm malignant From CILTACABTAGENE AUTOLEUCEL?
Of the 13 reports, 6 (46.2%) resulted in death, 2 (15.4%) required hospitalization.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CILTACABTAGENE AUTOLEUCEL. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does CILTACABTAGENE AUTOLEUCEL Cause?
Cytokine release syndrome (570)
Pyrexia (242)
Immune effector cell-associated neurotoxicity syndrome (232)
Parkinsonism (209)
Hospitalisation (193)
Adverse event (143)
Neurotoxicity (140)
Death (130)
Malaise (126)
Fatigue (123)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which CILTACABTAGENE AUTOLEUCEL Alternatives Have Lower Neoplasm malignant Risk?
CILTACABTAGENE AUTOLEUCEL vs CIMETIDINE
CILTACABTAGENE AUTOLEUCEL vs CIMZIA
CILTACABTAGENE AUTOLEUCEL vs CINACALCET
CILTACABTAGENE AUTOLEUCEL vs CINNARIZINE
CILTACABTAGENE AUTOLEUCEL vs CINRYZE